A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients. [electronic resource]
- Transplantation proceedings Apr 1996
- 987 p. digital